217 related articles for article (PubMed ID: 33913256)
1. Pyrin Inflammasome Activation Abrogates Interleukin-1 Receptor Antagonist, Suggesting a New Mechanism Underlying Familial Mediterranean Fever Pathogenesis.
Mortensen SB; Hansen AE; Mogensen TH; Jakobsen MA; Beck HC; Harvald EB; Lambertsen KL; Johansen IS; Andersen DC
Arthritis Rheumatol; 2021 Nov; 73(11):2116-2126. PubMed ID: 33913256
[TBL] [Abstract][Full Text] [Related]
2. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.
Jamilloux Y; Lefeuvre L; Magnotti F; Martin A; Benezech S; Allatif O; Penel-Page M; Hentgen V; Sève P; Gerfaud-Valentin M; Duquesne A; Desjonquères M; Laurent A; Rémy-Piccolo V; Cimaz R; Cantarini L; Bourdonnay E; Walzer T; Py BF; Belot A; Henry T
Rheumatology (Oxford); 2018 Jan; 57(1):100-111. PubMed ID: 29040788
[TBL] [Abstract][Full Text] [Related]
3. Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype.
Omenetti A; Carta S; Delfino L; Martini A; Gattorno M; Rubartelli A
Ann Rheum Dis; 2014 Feb; 73(2):462-9. PubMed ID: 23505242
[TBL] [Abstract][Full Text] [Related]
4. The pyrin inflammasome aggravates inflammatory cell migration in patients with familial Mediterranean fever.
Akbaba TH; Akkaya-Ulum YZ; Demir S; Ozen S; Balci-Peynircioglu B
Pediatr Res; 2022 May; 91(6):1399-1404. PubMed ID: 33963299
[TBL] [Abstract][Full Text] [Related]
5. Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor.
Magnotti F; Malsot T; Georgin-Lavialle S; Abbas F; Martin A; Belot A; Fauter M; Rabilloud M; Gerfaud-Valentin M; Sève P; Duquesne A; Hot A; Durupt S; Savey L; Giurgea I; Grateau G; Henry T; Jamilloux Y
Ann Rheum Dis; 2021 Jan; 80(1):128-132. PubMed ID: 33037005
[TBL] [Abstract][Full Text] [Related]
6. Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients.
Magnotti F; Lefeuvre L; Benezech S; Malsot T; Waeckel L; Martin A; Kerever S; Chirita D; Desjonqueres M; Duquesne A; Gerfaud-Valentin M; Laurent A; Sève P; Popoff MR; Walzer T; Belot A; Jamilloux Y; Henry T
EMBO Mol Med; 2019 Nov; 11(11):e10547. PubMed ID: 31589380
[TBL] [Abstract][Full Text] [Related]
7. Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation.
Van Gorp H; Saavedra PH; de Vasconcelos NM; Van Opdenbosch N; Vande Walle L; Matusiak M; Prencipe G; Insalaco A; Van Hauwermeiren F; Demon D; Bogaert DJ; Dullaers M; De Baere E; Hochepied T; Dehoorne J; Vermaelen KY; Haerynck F; De Benedetti F; Lamkanfi M
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14384-14389. PubMed ID: 27911804
[TBL] [Abstract][Full Text] [Related]
8. Monocyte secretory profiling in a clinical and MEFV genotype-characterized cohort of Danish familial Mediterranean fever patients: diagnostic potential of CCL1 and CXCL1.
Mortensen SB; Hansen AE; Byg KE; Diederichsen L; Schade Larsen C; Goldschmidt MI; Jakobsen MA; Assing K; Lambertsen KL; Andersen DC; Johansen IS
Scand J Rheumatol; 2023 Mar; 52(2):181-189. PubMed ID: 35258407
[TBL] [Abstract][Full Text] [Related]
9. Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations.
Sugiyama R; Agematsu K; Migita K; Nakayama J; Mokuda S; Ogura F; Haraikawa K; Okumura C; Suehiro S; Morikawa S; Ito Y; Masumoto J
Mol Biol Rep; 2014 Jan; 41(1):545-53. PubMed ID: 24318677
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated production of interleukin-1β upon activation of the NLRP3 inflammasome in patients with familial Mediterranean fever.
Repa A; Bertsias GK; Petraki E; Choulaki C; Vassou D; Kambas K; Boumpas DT; Goulielmos G; Sidiropoulos P
Hum Immunol; 2015 Jul; 76(7):488-95. PubMed ID: 26074413
[TBL] [Abstract][Full Text] [Related]
11. Pyrin Inflammasome Activation Defines Colchicine-Responsive SURF Patients from FMF and Other Recurrent Fevers.
Palmeri S; Penco F; Bertoni A; Bustaffa M; Matucci-Cerinic C; Papa R; Drago E; Caorsi R; Corcione A; Bocca P; Scarone C; Rubartelli A; Volpi S; Gattorno M; Prigione I
J Clin Immunol; 2024 Jan; 44(2):49. PubMed ID: 38231350
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional licensing is required for Pyrin inflammasome activation in human macrophages and bypassed by mutations causing familial Mediterranean fever.
Mangan MSJ; Gorki F; Krause K; Heinz A; Pankow A; Ebert T; Jahn D; Hiller K; Hornung V; Maurer M; Schmidt FI; Gerhard R; Latz E
PLoS Biol; 2022 Nov; 20(11):e3001351. PubMed ID: 36342970
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1Ra rs2234663 and Interleukin-4 rs79071878 Polymorphisms in Familial Mediterranean Fever.
Nursal AF; Tekcan A; Kaya SU; Sezer O; Yigit S
Gene; 2016 May; 582(2):173-7. PubMed ID: 26861613
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever.
Bostanci V; Toker H; Senel S; Poyraz O; Akpinar A; Görgün EP; Bakar O
Clin Oral Investig; 2017 Jan; 21(1):469-475. PubMed ID: 27068409
[TBL] [Abstract][Full Text] [Related]
15. Study of the association of IL-1β and IL-1RA gene polymorphisms with occurrence and severity of Familial Mediterranean fever.
Ibrahim JN; Chouery E; Lecron JC; Mégarbané A; Medlej-Hashim M
Eur J Med Genet; 2015 Dec; 58(12):668-73. PubMed ID: 26585190
[TBL] [Abstract][Full Text] [Related]
16. [The role of interleukin-1 and interleukin-1-receptor antagonist in development of familial mediterranean fever and other autoinflammatory diseases].
Dzhidoian Z
Georgian Med News; 2011 May; (194):53-6. PubMed ID: 21685523
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the B30.2 and the central helical scaffold domains of pyrin differentially affect inflammasome activation.
Chirita D; Bronnec P; Magnotti F; Dalmon S; Martin A; Popoff M; Gerfaud-Valentin M; Sève P; Belot A; Contis A; Duquesne A; Nocturne G; Lemelle I; Georgin-Lavialle S; Boursier G; Touitou I; Jamilloux Y; Henry T
Cell Death Dis; 2023 Mar; 14(3):213. PubMed ID: 36966139
[TBL] [Abstract][Full Text] [Related]
18. Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis.
Park YH; Remmers EF; Lee W; Ombrello AK; Chung LK; Shilei Z; Stone DL; Ivanov MI; Loeven NA; Barron KS; Hoffmann P; Nehrebecky M; Akkaya-Ulum YZ; Sag E; Balci-Peynircioglu B; Aksentijevich I; Gül A; Rotimi CN; Chen H; Bliska JB; Ozen S; Kastner DL; Shriner D; Chae JJ
Nat Immunol; 2020 Aug; 21(8):857-867. PubMed ID: 32601469
[TBL] [Abstract][Full Text] [Related]
19. Gene-Dose Effect of
Stoler I; Freytag J; Orak B; Unterwalder N; Henning S; Heim K; von Bernuth H; Krüger R; Winkler S; Eschenhagen P; Seipelt E; Mall MA; Foell D; Kessel C; Wittkowski H; Kallinich T
Front Immunol; 2020; 11():716. PubMed ID: 32655537
[TBL] [Abstract][Full Text] [Related]
20. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS.
Park YH; Wood G; Kastner DL; Chae JJ
Nat Immunol; 2016 Aug; 17(8):914-21. PubMed ID: 27270401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
